SkinnyRx review

SkinnyRx for moms: our verdict

$199/mo semaglutide, $299/mo tirzepatide, with a sublingual tablet option — and an FDA warning letter to its parent, Lean Rx, Inc., dated 02/20/2026 that its own site never mentions. It runs about $199/mo, flat across every dose.

We looked at SkinnyRx the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What SkinnyRx actually costs

• Compounded semaglutide — Injectable: $199/mo
• Oral semaglutide — Sublingual tablets: $249/mo
• Compounded tirzepatide — Injectable: $299/mo
• Oral tirzepatide — Sublingual tablets: $299/mo

That's roughly in line with our list's median of ~$179/mo.

SkinnyRx prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

The medications SkinnyRx prescribes

SkinnyRx lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.

If you prefer an option without needles, check the exact product offered. FDA-approved oral semaglutide tablets have their own clinical trials and prescribing labels. Compounded oral or sublingual products are different: they are not FDA-approved and cannot be assumed equivalent to an approved tablet or injection. Ask the clinician about the formulation, evidence and instructions.

Where it operates. SkinnyRx publishes no state list, so confirm it serves yours before you pay anything.

Where SkinnyRx fits — and where it doesn't — for moms

A good fit if…

• you want to discuss both semaglutide and tirzepatide with your prescribing clinician.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
• you need to discuss the right timing around pregnancy and nursing with your treating clinician before choosing. If comparing prices with CoreAge Rx, request the offer and terms separately from that clinical decision.

Trust, safety and oversight

Our confidence is moderate — the core data holds up, but some details (state availability, program mechanics) aren't fully public. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.

The bottom line

SkinnyRx is a provider we list only with the full story attached — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.